CAS: 21581-45-3; 2-(3,4-Dichlorophenyl)Ethanamine

该化合物是一种代用苯乙胺衍生物,其特点是苯环的3和4个位置存在氯原子,这种结构改变增强了其稳定性和反应性,使其成为有机合成中有价值的中间体,特别是在制药和农用化学品开发中.二氯替代模式影响其电子特性,有利于在复杂的合成途径中作出选择性反应.该化合物由于其潜在的反应性能,通常在受控条件下处理.其定义明确的化学特性和一贯的纯度使它适合于需要精确分子结构的科研应用.建议适当的储存和处理以保持稳定.

英文名称2-(3,4-Dichlorophenyl)Ethanamine
中文名称3,4-二氯苯乙胺
IUPAC名称2-(3,4-dichlorophenyl)ethanamine
其它别名Phenethylamine, 3,4-dichloro- (6CI,7CI,8CI); 1,2-Dichloro-4-(2-aminoethyl)benzene; Benzeneethanamine, 3,4-dichloro-; 2-(3,4-Dichlorophenyl)ethylamine; 3,4-Dichlorobenzeneethanamine; 3,4-Dichlorophenethylamine; 3,4-Dichlorophenylethylamine
CAS编号21581-45-3
MFCD编号:MFCD00060617
EINECS号:626-552-8
分子式:C8H9Cl2N
分子量:190.07
产品CID: 1120310
产品分类有机原料 → 氨基化合物

相似结构搜索
InChIKey: MQPUAVYKVIHUJP-UHFFFAOYSA-N
InChI=1S/C8H9Cl2N/c9-7-2-1-6(3-4-11)5-8(7)10/h1-2,5H,3-4,11H2…
计算化学: 氢键受体数1.0氢键供体数1.0可旋转键数2.0

物理性质

沸点268.8±25.0 °C at 760 mmHg
闪点116.4±23.2 °C
密度1.3±0.1 g/cm3
pKa:9.30±0.10(预测)
PSA:26.02
LogP:2.52
折射率1.570
蒸汽压0.0±0.6 mmHg at 25°C
外观形态透明无色至淡黄色液体
储存条件放入紧密的贮藏器内，储存在阴凉，干燥环境的地方
产品应用该化合物用于合成N-(3>,4--二氯基苯)乙基-4-甲环环乙烷[5.4.1.0 2,6.0.3,10.0.590.0,59.0,8,11]DODCAN-3-OL和2-[2-(3,4(2-二氯)苯基)乙氨基]-1--3-乙醇.

MSDS等安全信息

GHS象形图
GHS符号GHS07;
注释: Exclamation mark
危险类别特定目标器官毒性 - 单次接触类别3
皮肤腐蚀/刺激类别2
严重眼刺激类别2
皮肤腐蚀类别1B
严重眼损伤类别1
警示词Warning(警告)
危险描述H335 |可能引起呼吸道刺激.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
H314 |造成严重皮肤灼伤和眼损伤.
H318 |造成严重眼损伤.
防范说明P261-P264-P271-P280-P302+P352-P305+P351+P338
危险等级IRRITANT, TOXIC
UN编号2735
危险品标志Xi,T
安全声明26
危险类别码36/37/38
WGK Germany3

欧盟法规

ECHA物质C&L通报

上下游产品

合成工艺路线路线简述

合成目标产物 3,4-Dichlorophenethylamine 主要起始原料 3,4-Dichlorophenylacetonitrile
(文献来源)合成步骤主要原料 3,4-Dichlorophenylacetonitrile

3,4-二氯氯苄置于lithium Aluminium Tetrahydride,三氯化铝体系中,用乙醚,乙醇,水用作溶剂,化学反应生成3,4-二氯苯乙胺
参考文献:The Preparation Of Substituted Thionocarbamates
标题:The Preparation Of Substituted Thionocarbamates
摘要:描述了一系列取代硫代氨基甲酸酯的制备和性质.
Doi:10.1139/v60-278

海关参考信息

2902600000-乙苯
2903911000-邻二氯苯
2903991000-对氯甲苯
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-10458995-B2
优先权日:2016-03-25
标题 :Combinatorial synthesis and biomarker development
发明人：MOOLA MURALIDHAR REDDY
权利人:MOOLA MURALIDHAR REDDY
摘要:Provided herein are methods, kits, and compositions for use in the diagnosis and treatment of diseases. Peptoids recognized by Alzheimers disease specific antibodies are identified.

专利号:EP-0250254-B1
优先权日:1986-06-20
标题:Cis & trans stilbenes and their composition for the treatment of hypertension
摘要:Stilbenes of the formula (I): wherein Y, m, R<1>, R<2>, q, Alk, R<3>, n and R<4> are as defined herein and Ar<1> and Ar<2> are aromatic, including the salts and ammonium derivatives of formula (I), in treating angina, hypertension and cardiac arrhythmias. Pharmaceutical compositions, methods of use and synthesis and novel intermediates are also part of the invention.

专利号:US-5064962-A
优先权日:1989-02-23
标题:Diaminothiophenes
发明人：WIESENFELDT MATTHIAS; ETZBACH KARL-HEINZ
权利人:BASF AG
摘要:Diaminothiophenes of the formula or tautomers thereof, where R1 and R2 are each hydrogen or together are where T1 is hydrogen, alkyl or phenyl, T2 and T3 are, independently of one another, alkyl or phenyl, or T2 and T3 together with the nitrogen linking them are a heterocyclic radical, R3 is substituted amino and R4 is alkanoyl, benzoyl, cyano, nitro or where T4 is hydrogen, alkyl or phenyl and T5 is the radical of a primary amine or of an active methylene compound, are prepared as described. The present diaminothiophene compound is useful in the synthesis of dyes, crop protection agents and pharmaceuticals.

专利号:US-4652584-A
优先权日:1984-07-13
标题 :Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
发明人：CARSON JOHN R
权利人:MCNEILAB INC
摘要:Phenoxypropanol derivatives having a 2-acetylenic moiety on the phenyl group thereof of the following formula (I): ##STR1## and their use as anti-hypertensives, e.g. in man. Also part of the invention are pharmaceutical compositions and intermediates used in the synthesis.

专利号:US-4742084-A
优先权日:1983-11-21
标题 :Aralykyl (arylethynyl)aralkyl amines and their use as vasodilators and antihypertensives
发明人：CARSON JOHN R
权利人:MCNEILAB INC
摘要:Acetylenes of the formula (I): (I) wherein Y, m, R1, R2, q, Alk, R3 n and R4 are as defined herein and Ar1 and Ar2 are aromatic, including the salts and ammonium derivatives of formula (I), in treating angina, hypertension and cardiac arrhythmias. Pharmaceutical compositions, methods of use and synthesis and novel intermediates are also part of the invention.

专利号:US-4661635-A
优先权日:1983-11-21
标题 :Aralykyl (arylethynyl)aralkyl amines and their use as vasodilators and antihypertensives
发明人：CARSON JOHN R
权利人:MCNEILAB INC
摘要:Acetylenes of the formula (I): (I) wherein Y, m, R1, R2+L, q, Alk, R3, n and R4 are as defined herein and Ar1 and Ar2 are aromatic, including the salts and ammonium derivatives of formula (I), in treating angina, hypertension and cardiac arrhythmias. Pharmaceutical compositions, methods of use and synthesis and novel intermediates are also part of the invention.

其他信息查阅

连云港淳达化工科技有限公司

网址: http://www.chundachem.com
电话: 0518-88581638 13706140298👤

⚠️ 未注册 · 未认证企业

备注: 📌 数据来源说明：本展台内容基于各搜索引擎等公开数据整理，仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议，请通过页面底部联系方式告知我们，我们会尽快处理。

常州搏仁化学科技有限公司

网址: http://www.borenchem.cn
企业联系电话：0519-86926766;18961190520👤
地址:江苏省常州市钟楼区邹区时代广场８幢1517室

⚠️ 未注册 · 未认证企业

备注: 📌 数据来源说明：本展台内容基于各搜索引擎等公开数据整理，仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议，请通过页面底部联系方式告知我们，我们会尽快处理。

第 1 / 1 页

现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

实用工具

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献

参考文献:10.1016/j.bmc.2018.05.011
摘要:Brear P, North A, Iegre J, Hadje Georgiou K, Lubin A, Carro L, Green W, Sore HF, Hyvönen M, Spring DR. Novel non-ATP competitive small molecules targeting the CK2 α/β interface. Bioorganic & Medicinal Chemistry. 2018 Jul;26(11):3016–20. doi: 10.1016/j.bmc.2018.05.011.
参考文献:10.1038/s41594-019-0253-7
摘要:Cheng MH, Bahar I. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nature Structural & Molecular Biology. 2019 Jul 03;26(7):545–56. doi: 10.1038/s41594-019-0253-7.